Artixio Introduces Regulatory Training Services for MedTech Industry
Artixio, a leading provider of regulatory compliance training, today announced the launch of its MedTech Regulatory Training services program for […]
Biologics in Autoimmune Diseases: A New Hope for Patients
Autoimmune diseases are complex and diverse, affecting millions of people globally with varying degrees of severity and symptoms. There are
Biosimilar Product Development: Regulatory Challenges & Key Insights
In this era where the demand for affordable healthcare is increasing every day, biosimilars that are replacements for biologics have
Document Management Systems (DMS) for Pharmaceutical Industry
A 21 CFR Part 11 compliance DMS is part of overall compliance and quality requirements across pharmaceutical organizations. Many tools
Bioconjugates: Combining the Best of Biologics and Small Molecules
Bioconjugates are molecules formed by chemically linking two or more molecules, typically involving a biological molecule like a protein, enzyme,
Biosimilars vs. Generics: Key Differences and Market Implications
In pharmaceuticals, biosimilars and generics are two important categories that often come up in discussions about drug affordability and accessibility.
Drug Master File (DMF): Meaning, Submission & Guidelines
The critical information about the CMC (Chemistry, Manufacturing and Control) aspect of an active pharmaceutical ingredient or a finished pharmaceutical
What Is Investigational New Drug & Types Of IND
The governing federal law makes it a compulsion for the pharmaceuticals to be subject to the marketing application for their
Import of Biological Specimens into India
A Biological specimen is a pharmaceutical product prepared by utilizing living cells and tissues to prevent, diagnose, or treat diseases.